Although courts have largely ruled in favor of the defendants citing lack of causation and federal pre-emption of state-law claims the litigation has highlighted the challenges of pharmacovigilance and the burden of proof in drug safety cases
Now, when it comes to this enzyme
Cardiovascular prevention now forms a third revenue pillar after the 2024 FDA approval enabling semaglutide use in overweight adults with heart disease
These medications are not suitable for everyone and may be contraindicated in patients with certain medical conditions including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, or diabetic retinopathy
Kawai T, Tanino F, Fukazawa M, et al
For semaglutide, the abdomen is generally the preferred starting site due to its faster absorption and ease of access